Mericitabine
Mericitabine is an experimental antiviral drug developed for the treatment of hepatitis C. It is a nucleoside analogue, which means it mimics the structure of nucleosides, the building blocks of DNA and RNA. Mericitabine is specifically a cytidine analogue, and it works by inhibiting the replication of the hepatitis C virus.
History[edit | edit source]
Mericitabine was developed by Roche, a Swiss multinational healthcare company. The drug entered Phase 2 clinical trials in 2008, and Phase 3 trials in 2011. However, in 2013, Roche decided to discontinue the development of Mericitabine due to the emergence of more effective treatments for hepatitis C.
Mechanism of Action[edit | edit source]
Mericitabine works by inhibiting the RNA-dependent RNA polymerase (RdRp) of the hepatitis C virus. RdRp is an essential enzyme for the replication of the virus. By inhibiting this enzyme, Mericitabine prevents the virus from replicating and spreading in the body.
Clinical Trials[edit | edit source]
In clinical trials, Mericitabine was generally well tolerated and showed promising antiviral activity. However, it was less effective than newer treatments, such as sofosbuvir and ledipasvir, which led to the discontinuation of its development.
See Also[edit | edit source]
 | This medical article is a stub. You can help WikiMD by expanding it. |
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
